ADVERTISEMENT
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis

Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.

Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.

publishing, disease & medicine, microbiology

Exclusive
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Catherine Offord | May 30, 2020 | 9 min read
Scientists have raised questions about the dataset published in The Lancet last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.
ADVERTISEMENT